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Renal function in the elderly: Impact of hypertension and cardiac
function. In senescence renal function is thought to decline markedly even
in the absence of renal disease. It has also been proposed that the changes
in renal function with age are not uniform and that confounding factors
such as hypertension or atherosclerosis may play a rote. We performed a
comprehensive study to compare several aspects of renal function in four
groups: (i) young healthy normotensive subjects (N = 24; 13 males; mean
age 26 3 years); (ii) elderly healthy normotensive subjects (elderly NT;N = 29; 13 males; 68 7 years); (iii) elderly treated and untreated
hypertensive patients (elderly HT; N = 25; 13 males; 70 6 years); and(iv) elderly patients with compensated mild to moderate heart failure
(elderly HF; N = 14; 6 males; 69 6 years). Compared to young subjects
mean GFR (C1,,) and ERPF (CPA11) were significantly lower in the elderly,
despite similar mean plasma creatinine levels (young, 121 11, 650 85
ml/min/1.73 m2; elderly NT, 103 11, 486 102; elderly HT, 103 13,
427 55; elderly HF, 92 14, 377 103). Nevertheless, GFR was within
the normal range in the majority of elderly NT and HT, but not in elderly
HF. ERPF was significantly lower in elderly HT as compared with elderly
NT, and still lower in elderly HF. Mean renovascular resistance and
filtration fraction were significantly higher in the elderly, particularly in
elderly HT and HF as compared with the young. Mean fractional
excretion of Na was similar in all groups studied, but the lithium
clearance was significantly lower in the elderly, suggesting a greater
proximal and less distal sodium reabsorption in senescence. In the elderly,
mean PTH concentration and urinary excretion of pyridoline cross-links
were significantly higher and mean 25-(OH)D3, calcitriol and phosphate
concentrations significantly lower; the correlation between PTH and GFR
was significant (r = —0.432, P < 0.001). The results document that the
decrease in renal hemodynamics with senescence is less marked than
suggested by some studies using less stringent methodology and inclusion
criteria. Comorbid conditions confound renal function in the elderly.
Age-associated changes in renal hemodynamics are accompanied by
significant alterations of renal hormones and of renal sodium handling.
It has been reported that glomerular filtration rate (GFR) and
effective renal plasma flow (ERPF) decline markedly with age
even in the absence of renal disease [1—51. It is commonly assumed
that at age 80 years GFR and ERPF are approximately 50%of the
values seen after puberty [1, 6]. These statements are based in part
on results of studies which used less than ideal methodology,
particularly endogenous creatinine clearance (Cr). Furthermore,
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comorbid conditions which may impact on renal function, such as
atherosclerosis, hypertension or heart failure, were not always
taken into consideration [7, 8]. Finally, dietary intake of protein
and salt were not monitored, although they are known to con-
found GFR in the elderly [1
The question arises whether one can identify risk factors that
impair renal function in the elderly. Lindeman, Tobin and Shock
[81 made the important observation that the decline in renal
hemodynamics was particularly pronounced in the elderly patient
with hypertension. Further, in the elderly cardiac dysfunction is
common, but the impact of (latent) heart failure on renal function
in the elderly has not been investigated in detail. Finally, it is
legitimate to ask whether the changes in renal hemodynamics are
accompanied by alterations in renal handling of sodium, calcium
and phosphate, and contribute to age-associated changes of
volume-regulating hormones (renin) or calcium-regulating hor-
mones (parathyroid hormone, calcitriol) [10, 111.
To address these issues we performed a comprehensive study to
compare renal hemodynamics, urinary albumin and electrolyte
excretion, plasma renin activity (PRA), parathyroid hormone
(PTH) and calcitriol concentrations in (i) young healthy normo-
tensive subjects and in three groups of elderly individuals, that is,
(ii) elderly healthy normotensive subjects, (iii) elderly hyperten-
sive patients, and (iv) elderly patients with compensated mild to
moderate heart failure (NYI-IA 1/Il).
Methods
Participants
The protocol of the present study was approved by the Ethics
Committee of the University of Heidelberg, Germany. All partic-
ipants gave their written informed consent; none of them was
participating in another study. Twenty-four young healthy normo-
tensive subjects were recruited among students of the University
of Heidelberg and 29 elderly healthy normotensive subjects were
recruited among members of the Academy for Elderly in Heidel-
berg. Both groups were matched for body weight. In addition, 25
elderly treated and untreated hypertensive patients without clin-
ical signs of atherosclerotic vascular disease and/or heart failure
(excluded by echocardiography) were recruited from the outpa-
tient department of the Division of Nephrology, University of
Heidelberg. Hypertension was defined according to WHO criteria
as blood pressure > 140/90 mm Hg (on three seperate occasions)
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or antihypertensive medication. Further, 14 elderly patients who
had undergone echocardiography and heart catheterization and in
whom mild to moderate heart failure (NYHA I/I!) was confirmed,
were recruited from the outpatient department of the Division of
Cardiology. Nine of these patients had coronary heart disease,
three had dilatated cardiomyopathy and two had valvular heart
disease. All patients were compensated at the time of the study
and in none of them edema, S3 gallop or jugular venous distension
were present on physical examination. To exclude primary renal
disease sonography, urinanalysis (including phase-contrast mi-
croscopy), and serum chemistry were performed in all partici-
pants. Individuals with suspected renal disease were excluded
from the study. Only subjects with normal renal function as
confirmed by measurement of plasma creatinine concentration
were included into the study. All participants were Caucasians.
Protocol
All participants were studied under outpatient conditions.
Dietary counselling was given to all participants, who were
advised to ingest a diet containing approximately 4000 mg (175
mmol) of sodium, 1000 mg of Ca2 and 1 g/kg protein per day.
They were advised not to make any dietary changes at least one
week prior to and during the examination. They were thoroughly
instructed how to collect a 24-hour urine sample in order to assess
the endogenous creatinine clearence and urinary albumin, urea
and electrolyte excretion. In parallel, ambulatory 24-hour blood
pressure was measured using an automatic blood pressure moni-
toring device (model 90207®; SpaceLabs Inc., USA). Cardiovas-
cular drugs with the potential to confound blood pressure and
renal hemodynamics were washed out in both groups of elderly
patients for at least three days prior to the 24-hour blood pressure
measurement.
On the morning of the next day GFR and ERPF were measured
after 12 hours of fasting in a quiet room and supine position using
the inulin (C10) and paraaminohippurate (CPA1!) infusion clear-
ance techniques as described previously [12]. In brief, a priming
dose of 1500 mg inulin/m2 (mutest®, Laevosan Co., Austria) and
of 500 mg paraaminohippurate/m2 (Nephrotest®, BGA, Ger-
many) was followed by continuous inulin (10 mg!m2!min) and
paraaminohippurate (8 mg!m2/min) infusion with ultraprecise
pumps (Perfusor FT®, Braun Melsungen, Germany). After an
appropriate equilibration period, blood samples for determina-
tion of C,0 and CPAFI were taken at regular intervals. In parallel,
the lithium clearance was measured. For this purpose the partic-
ipants had received 450 mg (12 mmol) lithium-carbonate at
10 p.m. on the preceding evening. Urine was collected from 8 a.m.
to 11 a.m. for measurements of sodium and lithium excretion. In
addition, blood samples for measurements of PRA, PTH, vitamin
D, electrolyte and serum lipid concentrations were taken without
venous compression at the start of the clearance measurement
after at least 60 minutes of supine position. Blood samples for
measurement of lithium and sodium concentrations were taken at
8 a.m. and 11 am. Mean arterial blood pressure (MAP) and heart
rate were measured with a non-invasive oscillometric technique
(Dinamap®, Criticon Inc., USA) at regular intervals throughout
the clearance measurements. Body mass index (BMI) and waist!
hip-ratio (W/H ratio) were also assessed. For the measurment of
pyridoline and desoxypyridoline concentrations a spot urine sam-
ple was obtained on a separate day in the none (between 11 a.m.
and 1 p.m.) after the subjects were up and about for several hours.
Measurements
Inulin was measured enzymaticaiiy using inulinase as described
by Kühnle, van Dahi and Schmidt [131 and paraaminohippurate
photometrically after the method of Bratton and Marshall [14].
Recovery of inulin with the enzymatic technique was 93 5%.
Replicate measurements of C10 in the same individual showed a
mean coefficient of variation of less than 4% (3 repeated mea-
surements in 5 individuals). Urinary albumin excretion rate was
measured with nephelometry (Protein array®; Beckmann Instru-
ments, Germany). Plasma and urine chemistry was analyzed with
autoanalyzer (Hitachi 705; Boehringer Mannheim, Germany) or
flame photometry (AFM 5051; Eppendorf, Germany). Plasma
and urine lithium was measured with atomic absorption photom-
etry. PRA (normal range 0.3 to 1.2 ng AI!ml!hr) was measured
with radioimmunoassay (RIA), and PTH concentrations (normal
range 1.2 to 6.0 pmol/liter) immunoradiometrically (IRMA),
25-(OH)D3 (normal range 50 to 300 nmol!liter) and 1,25-
(OH)2D3, that is, calcitriol (normal range 30 to 70 pg/mi) with
RIA. Urinary pyridoline (normal range for male, 100 to 250 JLg!g
creatinine; female, 120 to 260 jtg/g creatinine) and desoxypyrido-
line (normal range for male, 16 to 52 rg/g creatinine; female, 20
to 52 ig/g creatinine) concentrations were measured with HPLC.
Calculations
The clearances of inulin (C10) and PAR (CPAU) were calculated
from the delivered dose: C = (' X I)/S; where C is the
clearance, 'r is the infusion rate (mi/mm), I is the concentration
of the analyte in the infusion fluid (mg/mi) and S is the plasma
concentration of the analyte (mg/mi). Filtration fraction (FF) was
calculated as the ratio Cfl/CPAH and renal vascular resistance
(RVR) was calculated using the equation: RVR = [(MAP — 12)
X 722.69/ERPF] X (1 — Hct); where Hct is hematocrit. The
creatinine clearance was calculated after Cockroft and Gault [151:
body wt (kg) X (140 — age)/0.814 X serum-creatinine (tmol!
liter). The value was multiplied with 0.85 for women. The
fractional excretion of sodium (FENa) was calculated as the ratio
between urinary Na excretion rate (UNa >( V) and filtered Na
load (GFR x plasma Na). The fractional reabsorption of
sodium in the proximal tubule, that is, the fractional proximal
reabsorption of sodium (FPRNa) was calculated as: FPRNa = 1 —
(CLI/GFR) [16]. The fractional reabsorption of sodium in the
distal tubule, that is, the fractional distal reabsorption of sodium
(FDRNa) was calculated as: FDRNO = I — (CNa/CLj), where CNa
is the sodium clearance and CL the lithium clearance. The daily
protein intake (DPI) of participants (in g!day) was calculated from
the 24-hour urea excretion as follows: DPI = 3 X urea excretion
in the 24-hour urine sample + 15 [17].
Statistics
The SAS package was used for statistical analysis. The normal-
ity of data distribution was tested with the Shapiro-Wilk test.
Comparison between groups was done using an analysis of
variance (ANOVA). A two-tailed t-test for comparison of random
data between groups was used when ANOVA gave significant
differences. Bonferroni correction was applied in order to account
for multiple comparisons. Data on urinary albumin excretion were
not normally distributed and were therefore analyzed with the
non-parametric Kruskai-Wallis test. Pearson's correlation analysis
was done between the inulin, the endogenous (Ccr) and the
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Table 1. Characteristics of the study populations
Young
healthy(N = 24)
Elderly
healthy(N = 29)
Elderly
hypertensive
(N =25)
Elderly with
heart failure
(N = 14)
Age years 26 3 68 7" 70 6" 69 6"
Gender males/females 13/11 13/16 13/12 6/8
BMI (kg/rn2) 22.4 1.5 25.1 3.2a 28.0 45h 26.2 41ah
Body wt kg 71 8° 71 12" 77 13 72 12
W/H ratio 0.80 0.04 0.84 0.08" 0.88 0.06 0.86
24-Hour MAP mm Hg 87 5" 91 7" 106 10 92 13"
MAP mm Hg 82 7 101 13° 119 13 98 19°
Sch,I mg/dl
STri mg/dl
175 26
95 47°
217 39"
101 52"
232 29"
142 54l
216 38"
157 55b
DPI g/day 78 16" 76 19° 77 16" 74 19"
DPI/body wt g/kg/day 1.1 0.2" 1.1 0.3° 1.0 0.2" 1.1 0.3"
UNaV mmol/24 hr 192 48" 182 64" 181 57" 193 67°
Abbreviations are: BMI, body mass index; body wt, body weight; W/H ratio, waist/hip ratio; 24 hr MAP, 24 hour MAP by Spacelab; MAP, MAP by
Dinarnap during the clearance period; SchOl, serum cholesterol; STrig, serum triglyzerides; DPI, daily dietary protein intake; DPI/body wt, dietary protein
intake factored for body weight; UNaV, 24 hr urinary sodium excretion. The statistical differences are given at a P level of 0.05 only; shared superscripts
are not significantly different.
calculated (Cockroft-Gault) creatinine clearance in all groups
studied. Further, the correlation between GFR (C1) and protein
intake, PTH concentrations or urinary pyridoline and desoxypyri-
doline excretion was calculated, as well as the correlations be-
tween 25-(OH)D3, calcitriol and PTH concentrations. In addition,
multiple regression analysis was performed between GFR as
dependent variable and age, MAP, BMI and heart failure as
independent variables. The analysis was repeated for ERPF, FF
and RVR as dependent variables. The differences were consid-
ered as significant at a P level of 0.05. All data are presented as
mean SD.
Results
Demographic data
Table 1 shows mean age, gender, mean BMI, body wt, waist/
hip-ratio, 24-hour ambulatory MAP (measured with SpaceLabs),
MAP measured on the clearance day with Dinamap, serum
cholesterol and triglyceride concentrations, dietary protein intake
estimated from urea excretion values (factored for body wt) and
24-hour urinary sodium excretion. Young and elderly healthy
subjects were matched for body wt, but because the young subjects
were taller their BMI was lower, The elderly hypertensive patients
had a significantly higher mean body wt, BM1, waist/hip-ratio and
24-hour MAP than the young and elderly healthy volunteers.
Mean 24-hour MAP was similar in young and elderly healthy
normotensive subjects and in elderly patients with heart failure. In
contrast to the ambulatory measurements, mean MAP as mea-
sured with Dinamap during the clearance study was significantly
higher in all three groups of elderly individuals as compared with
the group of young subjects. In fact, mean MAP measured with
Dinamap was much higher than the 24-hour ambulatory blood
pressure measurement in all three groups of elderly subjects,
whereas it was actually lower in the young individuals. Mean
serum cholesterol and triglyceride levels were significantly higher
in all elderly groups as compared with the young subjects. In
addition, triglycerides were significantly higher in elderly patients
with hypertension and in patients with heart failure than in the
healthy elderly. Mean dietary protein intake (factored for body
wt) and 24-hour urinary sodium excretion were similar in all
groups studied. There was a modest, but significant correlation
between dietary protein intake and GFR (r = 0.280; P < 0.02).
Renal hemodynamics
Figure 1 shows individual data on GFR. Mean GFR as mea-
sured with the inulin clearance technique was significantly lower
in all three groups of elderly individuals as compared with the
young healthy subjects despite similar mean plasma creatinine
concentrations in all groups studied (Table 2). Sixty-six percent
(19 of 29) of elderly healthy subject and 64% (16 of 25) of elderly
hypertensive patients had a GFR within the normal range (that is,
lower 95% confidence interval of GFR in young healthy sub-
jects = 99 ml/min/l.73 m2), whereas only 29% (4 of 14) of elderly
patients with mild to moderate heart failure had a normal GFR.
There were no significant differences in mean C1 between the
normotensive and hypertensive elderly individuals, but GFR was
significantly lower in elderly patient with heart failure as com-
pared with healthy normotensive elderly subjects and hyperten-
sive elderly subjects. Mean GFR tended to be lower in the elderly
hypertensive subjects who had a history of treatment with antihy-
pertensive drugs, but were off treatment at the time of the study
(N = 16; 101 13 ml/min/1.73 m2), than in the untreated elderly
hypertensive subjects (N = 9; 106 13), but the difference was
not statistically significant. By the multiple regression analysis
GFR was significantly affected by age (r = —0.46,P < 0.001) and
heart failure (—0.27, P < 0.01), but not by MAP (r = 0.18, P <
0.07) or BMI (r = 0.11, P< 0.30).
Both the measured (C) and the calculated (Cockroft-Gault)
creatinine clearances were significantly lower than the C1,, in all
elderly subjects, but not so in young subjects (Table 2). The
correlations between the Cr and C1,, (r = 0.60; P < 0.001), the
calculated (Cockroft-Gault) creatinine clearance and Ci,, (r =
0.69; P < 0.001) and the Ce,. and Cockroft-Gault clearance (r =
0.71; P < 0.001) were significant in all groups.
Mean ERPF (CpA}) was significantly lower in all three groups
of elderly subjects than in the young healthy volunteers (Fig. 2 and
Table 2). There was a progressive decline in ERPF in the three
groups of elderly individuals, ERPF being significantly higher in
healthy elderly subjects than in elderly subjects with hypertension
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Fig. 1. Individual data on glomendar filtration rate (GFR) in young healthy
normotensive subjects (N 24; mean age 26 3 years), elderly healthy
normotensive subjects (N = 29; 68 7 years), elderly hypertensive patients
without heart ftiilure (N = 25; 70 6 years) and elderly patients with
compensated mild to moderate (NYHA I/Il) heart failure (N 14; 69 6
years). Symbols are: (0) men, (•) women; ()mean value.
and in elderly patients with heart failure. Only 45% (13 of 29)
percent of elderly healthy subjects, 24% (6 of 25) of elderly
hypertensive subjects and 21% (3 of 14) of elderly patients with
heart failure had an ERPF within the normal range (lower 95%
confidence interval of the ERPF in young healthy subjects = 480
mlIminhl.73 m2). Conversely, mean RVR (Fig. 3) and mean FF
(Table 2) were significantly higher in all three groups of elderly
individuals as compared with young subjects. Again, RVR and FF
were higher in elderly patients than in healthy elderly individuals.
Further, when analyzed separately, mean ERPF tended to be
lower (424 62 vs. 432 43 ml/min/1.73 m2; NS) and mean RVR
higher (172 34 vs. 150 26 mm Hg/mi/mm; P < 0.05) in elderly
hypertensive with a history of antihypertensive treatment. By the
multiple regression analysis ERPF was significantly affected by
age (r = —0.56, P < 0.001) and heart failure (—0.25, P < 0.01),
but not by MAP (r =
—0.17, P < 0.17) or BMI (r = —0.04, P <
0.70). In contrast, the FF was significantly affected by MAP (r =
0.34, P < 0.002) and heart failure (r = 0.32, P < 0.003), but not
by age (r = 0.21, P < 0.06) or BMI (r = 0.05, P < 0.64). Finally,
the RVR was significantly affected by age (r = 0.47, P < 0.001),
MAP (r = 0.40, P < 0.001) and heart failure (r = 0.21, P < 0.01),
but not by BMI (r = 0.06, P < 0.44).
The urinary albumin excretion rate was in the normal range in
all young subjects examined; it was increased above the conven-
tional normal limit of 30 mg/24 hr in 2 of 29 elderly healthy
subjects, in I of 25 elderly hypertensive patients and in 1 of 14
elderly patients with heart failure (Table 2). The mean albumin
excretion rate tended to be higher in elderly than in young
subjects.
Renal sodium handling
There were no significant differences in mean 24-hr urinary
sodium excretion and FENa between all four groups studied
(Table 3). Despite similar urinary sodium excretion PRA was
significantly lower in the elderly. The mean lithium clearance was
significantly lower in all three groups of elderly subjects as
compared with the group of young volunteers. Correspondingly,
fractional proximal sodium reabsorption was significantly higher
and distal fractional reabsorption of sodium lower in elderly
subjects as compared with young subjects.
Calcium metabolism
Table 4 shows parameters of Ca2 metabolism. Mean total
plasma calcium concentrations were similar in healthy young and
elderly subjects and in elderly hypertensives, whereas it was higher
in the elderly patients with heart failure (but they had also a
higher total plasma protein concentration; data not shown). Mean
plasma phosphate levels were significantly lower and PTH con-
centrations significantly higher in the elderly. The correlation
between PTH concentrations and GFR (C1) was highly signifi-
cant (r =
—0.43; P < 0.001). Mean plasma calcitriol concentration
was significantly higher (P < 0.05) in young than in elderly
subjects when data of all three elderly groups were pooled. There
was no individual among the younger subjects with 25-(OH)D3
concentration below 50 nmol/liter, whereas in 14% (4 of 29) of
healthy elderly subjects, in 12% (3 of 25) of elderly hypertensive
subjects and in 43% (6 of 14) of elderly patients with heart failure
25-(OH)D3 concentration was below the lower limit of recom-
mended vitamin D status. The correlation between PTH and
calcitriol concentrations (r =
—0.39; P < 0.002), between PTH
and 25-(OH)D3 concentrations (r =
—0.33; P < 0.005) and
between calcitriol and 25-(OH)D3 concentrations (r = 0.42; P <
0.001) were significant. There were no significant differences in
24-hour urinary calcium and phosphate excretion between the
groups studied, although urinary calcium tended to be lower in the
elderly. The urinary excretion rates of pyridoline and desoxypyri-
doline were significantly higher in all elderly groups as compared
with the young subjects, but were still in the (upper) normal range.
The correlation between GFR and urinary excretion of cross-links
(pyridolirie, r =
—0.43, P < 0.001; desoxypyridoline, r = —0.35;
P < 0.002) was significant.
Discussion
The present cross-sectional study documents that (i) GFR
(measured as inulin clearance) is only modestly lower in healthy
elderly than in young healthy individuals, and that (ii) cardiovas-
cular diseases such as hypertension and heart failure have a major
adverse effect on renal hemodynamics and other aspects of renal
function. We emphasize that dietary protein (and sodium) intake
was similar in all groups studied. This is of relevance, since results
from a recent study suggest that the age-related decline in GFR
may be also a function of low dietary protein intake [9].
Based on more recent studies GFR has been reported to
decrease from approximately 120 ml/min/1.73 m2 at the begining
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Table 2. Parameters of renal function in the study populations
Young Elderly Elderly Elderly with
healthy healthy hypertensive heart failure(N 24) (N = 29) (N = 25) (N = 14)
GFR ml/min/].73 m2 121 11 103 U" 103 13" 92 14
ERPF ml/min/L73 m2 650 85 486 102 427 55" 377 103"
FF CI/CPAH 0.19 0.02 0.22 0.04 0.24 0.03" 0.26 0.06"
RVR mm Hg/mI/mm 71 9 125 31 164 33" 162 50'
PmgIdl 0.9±0.1" 0.9±0.1k' 1.0±0.2' 1j02h
Ucr mg/dl 1563 322 1095 402" 1199 409" 1036 332"
Uarea g/24 hr 21 5" 20 6" 21 5" 22 10"
UAIb mg/24 hr 2.7 1.2" 3.6 6.7a 4.6 6.6" 8.8 12.5"
Ccr mi/mm 117 20 81 23" 85 29" 71 26
Ccr ml/min/1.73 m2 107 15 78 18" 81 29" 68 2P
Ccr cale mI/mm 115 20 71 isa 72 20" 63 19k'
1000 -
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600 -
Abbreviations are: GFR, glomerular filtration rate; ERPF, effective renal plasma flow; FF, filtration fraction; RVR, renal vascular resistance; Cr'
plasma creatinine concentration; Ucr, 24-hr urinary creatinine excretion; Uarca, 24-hr urinary urea excretion; Car, 24-hr endogenous creatinine
clearance; Ccr calc, calculated creatinine clearance after Cockroft-Gault. The statistical differences are given at a P level of 0.05 only; shared superscripts
are not significantly different.
300
o 0
250 o
o 200 4S
• 0 •
•
150 4
0
100 4 ° 8S0
• S
E P 50
o
o 8 0-
0
.
500 -
400 -
300 -
0
0
0
.
.
I
0
.
.200 —
100 -
I— I-z I
C)C a)
>- w uj i:ic.C
Fig. 2. Individual data on effective renal plasma flow (ERPF) in young
healthy normotensive subjects (N = 24; mean age 26 3 years), elderly
healthy normotensive subjects (N = 29; 68 7 years), elderly hypertensive
patients without heart failure (N = 25; 70 6 years) and elderly patients with
compensated mild to moderate (NYI-JA I/Il) heart failure (N = 14; 69 6
years). Symbols are: (0) men, (•) women; (4) mean value.
of the fourth decade to about 90 ml/min/1.73 m2 in the sixth
decade, and to remain virtually stable thereafter [18—201. In our
healthy elderly individuals with a mean age of 68 years, the mean
C1,., was even above 100 ml/min/1.73 m2 and GFR remained within
a)H H
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Fig. 3. Individual data on renal vascular resistance (RVR) in young healthy
normotensive subjects (N = 24; mean age 26 3 years), elderly healthy
normotensive subjects (N = 29; 68 7 years), elderly hypertensive patients
without heart failure (N = 25; 70 6 years) and elderly patients with
compensated mild to moderate (NYHA I/lI) heart failure (N = 14; 69 6
years). Symbols are: (0) men, (•) women; (') mean value.
the normal range in 2/3 of them. This finding is in agreement with
previous data of our own and of cross-sectional [12, 20] and
longitudinal [21] studies on renal function with advancing age. In
the latter study, that is, the Baltimore Longitudinal Study on
Aging, an unchanged GFR was found in up to 30% of elderly
people [211. In this study GFR was estimated as endogenous
creatinine clearance in contrast to most cross-sectional studies.
On the other hand, the present study shares the drawbacks of
cross-sectional studies, that is, lack of completly suitable control
groups. Our group of elderly healthy subjects might have been
more active than the average elderly. Further, potential effects of
Fliser et al: Renal function in the elderly 1201
Table 3. Renal electrolyte handling and plasma renin activity in the study populations
Young
healthy(N = 24)
Elderly
healthy(N = 29)
Table 4. Calcium metabolism in the study populations
Elderly
hypertensive(N = 25)
Elderly with
heart failure
(N = 14)
Young
healthy(N = 24)
Elderly
healthy(N = 29)
Elderly
hypertensive(N = 25)
Elderly with
heart failure
(N = 14)
Ca mmol/liter
P. mmol/liter
2.31 0.14"
1.18 0.13
2.30 0.09"
1.08 0.15"
2.32 0.10"
0.98 012b
2.39 0.08
1.02 0.l8"'
PTHpmol/liter 2.8 1.1 4.4 1.4" 5.0 1.4" 6.6 4.2"
25-(OH)D3 nmol/liter 112 52 75 31" 77 35" 65 32"
Calcitriol pg/mI 57 13" 53 9ah 50 11h 44 12
U. mmol/24 hr 4.6 2.0" 4.3 2.2" 3.6 2.1 3.3 2.4a
U. mmol/24 hr 28 8" 25 9" 24 7" 26 8'
U p.g/g creatinine 177 34 253 70" 243 54" 253 60"
U0 1g/g creatinine 35 8 47 14" 45 16" 47 18"
Abbreviations are: P and P, plasma calcium and phosphate concentrations; PTH, intact parathyroid hormone; 25-(OH)D3, hydroxy vitamin D; Ua
and Ui,, 24-hr urinary calcium and phosphate excretions; U and U1-, urinary pyridoline and desoxypyridoline excretion (spot urine). The statistical
differences are given at a P level of 0.05 only; shared superscripts are not significantly different.
socio-economical differences and differences in lifestyle between
healthy students and healthy elderly subjects cannot be com-
pletely ruled out. In addition, the secular trend for the younger to
be taller and the redistribution of body fat in the elderly made it
impossible to perfectly match elderly and young subjects for BMI.
The elderly subjects had also significantly higher serum lipid
concentrations. It is conceivable that higher serum lipids impact
on renal function.
Some studies had already pointed to hypertension as an impor-
tant confounder of renal function, since a more marked reduction
of GFR with age was noted in the hypertensive elderly [8, 22].
This is in apparent contrast with our findings, but the present
study differs in several respects. First, we washed out all cardio-
vascular medications, particularly diuretics, which may interfere
with GFR. Second, when separately analyzing untreated elderly
hypertensives and hypertensive individuals with a history of drug
treatment, the latter had a lower mean GFR and higher renovas-
cular resistance. Obviously more severe hypertension adversely
affects GFR, and this may have had more of an impact in past
studies than in our group of patients with relatively modest
hypertension. When the results of the Baltimore Longitudinal
Study on Aging are compared with the present study, it is
important that the former study included (hypertensive) individ-
uals with diuretic treatment for edema of undefined origin [8].
We confirmed previous observations from our and other labo-
ratories [2, 12, 23—25] that in the elderly ERPF is lower and FF
and RVR are higher. It is well known that aging is associated with
some loss of renal mass [26, 27]. Involution of tissue occurs
primarily in the renal cortex with relative sparing of the renal
medulla [25]. Selective loss of cortical and preservation of jux-
tamedullary nephrons with higher FF may explain, at least in part,
the rise in FF with age. The decrease in ERPF and increase in FF
and RVR was even more pronounced in our elderly patients with
high blood pressure and in elderly patients with heart failure (Fig.
3). This finding is in agreement with data from the study of
Schmieder, Schachinger and Messerli [28], who documented a
more pronounced decline of ERPF in elderly patients with
essential hypertension and even in elderly patients with borderline
hypertension as compared with normotensive elderly subjects.
Our results in elderly patients with heart failure clearly confirm
that age-related changes in renal hemodynamics depend on
coexistent cardiovascular pathologies such as hypertension, heart
failure or atherosclerosis [7], even if these conditions fail to cause
a major increase in plasma creatinine concentrations.
Our finding of well preserved GFR in the healthy elderly
despite an assumed decrease in renal mass with age would imply
that hyperfiltration takes place in the remaining nephrons. In the
past, we were able to document a well preserved renal reserve in
healthy elderly subjects [121 and this was confirmed by others [29,
'N mmol/liter 140 1" 140 2" 139 2" 139 2
P mmol/Iiter 102 3" 102 3" 101 3" 101 4"
K mmol/liter 3.9 0.3" 4.0 0.3" 4.0 0.3" 4.2 0.4"
FEN. % 0.8 0.2" 0.9 0.3" 0.9 0.3" 1.1 0.5"
CL mI/mm 27 12 14 7" 15 7" 12 a
FPRNa % 77 9 87 6" 86 7 87 s"
FDRN, % 96 2 92 6 93 5" 89 7
PRA ngAI/mI/hr 0.75 0.36 0.46 0.46" 0.35 0.27" 0.39 0.20"
Abbreviations are: EN., P and K, plasma sodium, chloride and potassium concentrations; FEN., fractional excretion of sodium; CLI, lithium
clearance; FPRN., fractional proximal reabsorption of sodium; FDRN., fractional distal reabsorption of sodium; PRA, plasma renin activity. Patients
who were treated with an ACE inhibitor in group 3 and group 4 were excluded from the analysis of PRA. The statistical differences are given at a P
level of 0.05 only; shared superscripts are not significantly different.
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30]. Despite uncertainties about the interpretation of renal re-
serve as a marker of hyperfiltration and the risk of progression,
however, this finding would argue against hyperfiltration of the
senescent kidney. It is of note that other findings also failed to fit
into the hyperfiltration concept. Recent post-mortem studies
failed to document a decrease in kidney weight when younger and
older individuals who had suffered traumatic death were matched
for body surface area [7]. Further, imaging studies showed only a
modest decrease in renal size with age [31, 32].
The observation that renal function is little affected by age may
have implications for the use of elderly donors for renal trans-
plantation. In most Western countries the disproportion between
demand for and availability of transplantable organs is a major
limitation for transplantation, and kidneys of healthy elderly
donors, that is, subjects above the age of 60 years, are increasingly
used [33—35]. Whether for long-term graft function GFR (in the
normal range) or RVR (clearly elevated) is more important, is
unclear and deserves further study.
It is also obvious that measured (C) and calculated (Cock-
croft-Gault) creatinine clearances lead to a marked underestima-
tion of true GFR in the elderly but not so in the young. To some
extent, spuriously low CCr may result from collection errors
despite careful instruction [36]. One finding consistent with this
argument is that C€ was particularly low in elderly females (data
not shown). Our data confirm previous reports that the Cockcroft-
Gault formula is unreliable for the estimation of GFR in elderly
subjects [37—39I This finding has implications for creatinine
(clearance) based adjustment of drug dosage in multimorbid
elderly patients.
It is controversial whether alburninuria increases with age
[40—42]. In our study only few of the elderly patients had albumin
excretion rates above the normal range. Nevertheless, the mean
albumin excretion rate in the elderly tended to be higher than in
the younger individuals. The finding of near normal albuminuria
is in good agreement with a previous study that showed no change
in fractional dextran clearance in elderly individuals [43]. In
contrast, in laboratory animals urinary protein excretion increases
markedly with age [44].
Another interesting finding is that of a substantial difference in
mean MAP between ambulatory 24-hour blood pressure com-
pared with Dinamap measurements during intervention (clear-
ance measurement) in the elderly, but not in the younger subjects.
It is in agreement with observations of others that conventional
sphygmomanometry overestimates the blood pressure burden
compared to ambulatory blood pressure measurements [45]. This
point to a greater "white coat effect" in the elderly.
Are changes in renal hemodynamics accompanied by changes in
renal handling of electrolytes? Using the lithium clearance tech-
nique Schou, Thomson and Vestergaard [46] found similar frac-
tional delivery of sodium from the proximal tubule in young and
elderly subjects. This observation is not confirmed by our data.
The lithium clearance was lower in all three groups of elderly
subjects on defined sodium intake, although fractional sodium
urinary excretion was similar as in young subjects. This implies
that sodium reabsorption is increased in proximal and reduced in
distal segments of the senescent nephron. Increased proximal
sodim reabsorption may contribute to the known tendency of
elderly to exhibit an expanded sodium space and salt sensitive
blood pressure [47—49]. It may also contribute, at least in part, to
supression of PRA in the elderly that was found by some [50, 51]
but not all authors [52]. The reasons for increased proximal
tubular sodium reabsorption are not clear but may be related to
increased filtration fraction and/or altered local activity of the
renin-angiotensin-aldosterone system.
Negative calcium balance and osteopenia are commonly found
in the elderly [11]. The extent to which this is related to abnormal
renal function is unknown. In our study the elderly subjects
tended to have lower calcium excretion and lower plasma phos-
phate concentrations, and this was paralleled by significantly
higher plasma intact PTH concentrations and urinary excretion of
indicators of bone resorption, such as pyridoline and desoxypyri-
doline, although the values remained within the normal range. A
significant correlation was found between GFR and PTH, impli-
cating that the kidney plays a causal role in activating the
parathyroidal glands. In our study nineteen percent of elderly had
25-(OH)D3 concentrations below 50 nmol/liter, that is, the lower
limit of recommended vitamin D status [53]. This finding confirms
numerous findings showing a high prevalence of latent vitamin D
insufficiency in the elderly [54, 55]. Further, there was a significant
correlation between 25-(OH)D3 and calcitriol concentrations.
Slightly lower calcitriol concentrations in the presence of higher
PTH are inappropriate, particularly in view of low 25-(OH)D3,
which is a tendency for substrate defiency. It is therefore sugges-
tive (although not directly documented by our measurements)
that higher PTI-I levels overcome low 25-(OH)2D1 concentrations,
that is, substrate deficiency, and cause near normal calcitriol
concentrations, but at the expense of a potential adverse effect of
higher PTH concentrations on bone. It is plausible to assume that
lower calcitriol and increased PTH concentration contribute to
disturbed bone structure in the elderly [55—58]. Reduced activity
of the renal hormone 1-alpha hydroxylase, that is, the rate-limiting
step in the generation of calcitriol, may be causaly involved,
similarly to what is seen in early renal failure [59]. Our observa-
tions suggests that in the genesis of senile osteoporosis comorbid
conditions which compromise renal function must be taken into
consideration.
It emerges from above that in the healthy elderly GFR is
modestly decreased at best. It is preserved at the expense of an
increased filtration fraction in a vasoconstricted kidney. These
age-related abnormalities of renal hemodynamics are more
marked in patients with comorbid conditions. The changes are
probably of minor significance under normal circumstances, but
the question arises whether in the elderly the changes in renal
function, particularly high FF, increase the risk for renal disease
to occur and to progress. This important point deserves further
studies, since several authors suggested that renal prognosis was
more adverse in the elderly in a variety of primary chronic
glomerular diseases [60, 61]. In several studies age emerged as an
independent predictor of renal prognosis.
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